Rola tomosyntezy oraz mammografii spektralnej w diagnostyce kobiet z gęstym utkaniem piersi

• Autorzy: Bojkowski Małgorzata , Wojnarska Aleksandra , Koper Beata

Warianty tytułu

EN

The role of tomosynthesis and spectral mammography in the diagnostic of women with dense breast

• Języki publikacji: PL

Abstrakty

PL

Podstawowym badaniem przesiewowym we wczesnym rozpoznawaniu raka piersi jest klasyczna mammografia rentgenowska. Ze względu na jej ograniczenia obserwowany jest ciągły rozwój nowych technik obrazowania piersi. Cyfrowa tomosynteza piersi DBT (Digital Breast Tomosynthesis) i mammografia spektralna CESM (Contrast Enhanced Spectral Mammography) znajdują szczególne zastosowanie w diagnostyce kobiet o gęstym utkaniu gruczołów piersiowych. Metody te są obecnie wykonywane jako badania uzupełniające w diagnostyce, stagingu oraz odpowiedzi na leczenie chemioterapią. Celem artykułu jest omówienie, w oparciu o literaturę, cyfrowej tomosyntezy piersi oraz mammografii spektralnej ze szczególnym uwzględnieniem ich zastosowania w diagnostyce uzupełniającej piersi o gęstej strukturze.

EN

The primary screening test for early diagnosis of breast cancer is classic X-ray mammography. Due to its limitations, continuous development of new breast imaging techniques is observed. DBT (Digital Breast Tomosynthesis) and spectral mammography CESM (Contrast Enhanced Spectral Mammography) are used especially in the diagnosis of women with dense breast gland. At present these methods are available as complementary studies in diagnostics, staging and response to chemotherapy. The aim of the article is to discuss, based on literature, digital tomosynthesis and spectral mammography with particular emphasis on their use in complementary diagnostics of densely structured breasts.

Słowa kluczowe

PL

cyfrowa tomosynteza piersi; mammografia spektralna; rak piersi; diagnostyka piersi

EN

digital breast tomosynthesis; spectral mammography; contrast enhanced spectral mammography; breast cancer; breast diagnostics

• Wydawca: Indygo Zahir Media
• Czasopismo: Inżynier i Fizyk Medyczny
• Rocznik: 2020
• Tom: Vol. 9, nr 3
• Strony: 203--206
• Opis fizyczny: Bibliogr. 19 poz., rys.

Twórcy

autor

Bojkowski Małgorzata

autor

Wojnarska Aleksandra

autor

Koper Beata

Bibliografia

• 1. Z. Momenimovahed, H. Salehiniya: Epidemiological characteristics of and risk factors for breast cancer in the world, Breast Cancer, Targets and Therapy, 11, 2019, 151-164.
• 2. F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal: Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA: A Cancer Journal for Clinicians, 68, 2018, 394-424.
• 3. J.M. Seely, T. Alhassan: Screening for breast cancer in 2018 – what should we be doing today?, Current Oncology, 25(Suppl 1), 2018, 115-124.
• 4. L. Lebron-Zapata, M.S. Jochelson: Overview of Breast Cancer Screening and Diagnosis, PET Clin, 13(3), 2018, 301-323.
• 5. D.B. Kopans: Digital Breast Tomosynthesis From Concept to Clinical Care, AJR, 202(2), 2014, 299-308.
• 6. B.K. Patel, M.B.I. Lobbes, J. Lewin: Contrast Enhanced Spectral Mammography: A Review, Seminars in Ultrasound, CT and MRI, 39(1), 2018, 70-79.
• 7. B.M. Haas, V. Kalra, J. Geisel, M. Raghu, M. Durand, L.E. Philpotts: Comparison of Tomosynthesis Plus Digital Mammography and Digital Mammography Alone for Breast Cancer Screening, Radiology, 269(3), 2013, 694-700.
• 8. A. Tingberg: Physics, technology and QC of breast tomosynthesis, Physica Medica, 52(Suppl. 1), 2018, 86.
• 9. S.-J. Lee, X. Chen, M.C. Mahoney: Diagnostic Role of Digital Breast Tomosynthesis, CDR, 41(22), 2018, 1-7.
• 10. M. Raghu, M.A. Durand, A. Goehler, H. Michalski, L. Geisel, R.J. Hooley, L.J. Horvath, R. Butler, H.P. Forman, L.E. Philpotts: Tomosynthesis in the Diagnostic Setting: Changing Rates of BI-RADS Final Assessment over Time, Radiology, 281(1), 2016, 54-61.
• 11. G. Gennaro, D. Bernardi, N. Houssami: Radiation dose with digital breast tomosynthesis compared to digital mammography: per-view analysis, Eur Radiol, 28(2), 2018, 573-581.
• 12. M.S. Jochelson, D.D. Dershaw, J.S. Sung: Bilateral contrast-enhanced dualenergy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma, Radiology, 266(3), 2013, 743-751.
• 13. C. Dromain, F. Thibault, S. Muller: Dual-energy contrast-enhanced digital mammography: initial clinical results, Eur Radiol, 21(3), 2011, 565-574.
• 14. F. Diekmann, C. Marx, R. Jong: Diagnostic accuracy of contrast enhanced digital mammography as an adjunct to mammography, Eur Radiol, 17, 2007, 174.
• 15. K.F. Ghaderi, J. Phillips, H. Perry, P. Lotfi, T.S. Mehta: Contrast-enhanced Mammography: Current Applications and Future Directions, RadioGraphics, 39(7), 2019, 1907-1920.
• 16. C. Bhimani, D. Matta, R.G. Roth, L. Liao, E. Tinney, K. Brill, P. Germaine: Contrast-enhanced Spectral Mammography: Technique, Indications, and Clinical Applications, Acad Radio, 24(1), 2016, 84-88.
• 17. R.M. Kamal, M.H. Helal, S.M. Mansour, M.A. Haggag, O.M. Nada, I.G. Farahat, N.H. Alieldin: Can we apply the MRI BI-RADS lexicon morphology descriptors on contrast-enhanced spectral mammography?, The British Journal of Radiology, 89(1064), 2016, 1-9.
• 18. M.B. Lobbes: The quality of tumor size assessment by contrast-enhanced spectral mammography and the benefits of additional breast MRI, Journal of Cancer, 6(2), 2015, 144-150.
• 19. V.A. McCormack, S. dos Santos: Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis, Cancer Epidemiology Biomarkers&Prevention, 15(6), 2006, 1159-1169.

Uwagi

Opracowanie rekordu ze środków MNiSW, umowa Nr 461252 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2021).